The partnership will use Masimo’s secure health data cloud and allow clinicians to remotely track signs of patient deterioration, according to a Jan. 18 Phillips news release. Among other metrics, the Masimo W1 watch can provide continuous pulse oximetry measurements.
The Masimo W1 watch is pending FDA clearance for use in medical applications.
